Kolexia
Mariani Pascale
Chirurgie viscérale
Clcc Institut Curie
Paris, France
131 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Métastase tumorale Tumeurs de l'uvée Tumeurs du foie Carcinomes Tumeurs colorectales Tumeurs du péritoine Carcinome épidermoïde Récidive tumorale locale

Industries

MEDAC SAS
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0): Study to Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (R0)
Essai Clinique (Institut Curie)   29 janvier 2024
FibroRect: Interest in Studying Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma : Exploratory Study
Essai Clinique (Institut Curie)   28 novembre 2023
Cancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction.
Nature communications   01 novembre 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
International journal of cancer   31 octobre 2023
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
Current oncology (Toronto, Ont.)   11 octobre 2023
139P Genomic prognostic and potential theragnostic factors in anal squamous cell carcinoma treated with abdominoperineal resection
Molecular Analysis for Precision Oncology Congress 2023 4-6 October 2023   01 octobre 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.
British journal of cancer   13 juillet 2023
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma.
Cancers   13 avril 2023
Un nouveau facteur de pronostic dans le mélanome de l'uvée métastatique
Institut Curie   31 mars 2023
Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma.
Annals of surgery   27 février 2023